3B Future Health Fund Investor
Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
Headquarters:
Luxembourg
Funding Status:
Active
Investment Stage:
Early Stage Venture
Founded Date:
2016-01-01
Industry:
Angel Investment
Investor Type:
Micro VC